Especially in recent years, with the development of molecular biology, a number of new biological markers for the prognosis of breast cancer, represented by WDR34 mRNA, provide novel target for the diagnosis and treatment of breast cancer (2). This evidence concerns the gene DYNC2I2 and breast cancer.